SERIES D PREFERRED STOCK PURCHASE AGREEMENTSeries D Preferred Stock Purchase Agreement • June 30th, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionTHIS SERIES D PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of February 22, 2023, by and among Notable Labs, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).